FLNA, filamin A, 2316

N. diseases: 571; N. variants: 85
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0016052
Disease: Fibromuscular Dysplasia
Fibromuscular Dysplasia
0.100 Biomarker disease BEFREE As unifocal FMD generally leads to more severe hypertension at younger age, we hypothesized that renal hemodynamics are more disturbed in unifocal renal artery FMD as compared with multifocal FMD, leading to increased renin secretion. 29889158 2018
CUI: C0016052
Disease: Fibromuscular Dysplasia
Fibromuscular Dysplasia
0.100 GeneticVariation disease BEFREE Frontometaphyseal dysplasia (FMD) is a dominant X-linked rare disease caused by mutations of FLNA. 29995760 2018
CUI: C0016052
Disease: Fibromuscular Dysplasia
Fibromuscular Dysplasia
0.100 Biomarker disease BEFREE Currently, the identification of areas that are at risk of FMD virus incursion and spread is a priority for FMD target surveillance after FMD is eradicated from a given country or region. 28552973 2017
CUI: C0016052
Disease: Fibromuscular Dysplasia
Fibromuscular Dysplasia
0.100 GeneticVariation disease BEFREE Frontometaphyseal dysplasia (FMD) is caused by gain-of-function mutations in the X-linked gene FLNA in approximately 50% of patients. 28498505 2017
CUI: C0016052
Disease: Fibromuscular Dysplasia
Fibromuscular Dysplasia
0.100 GeneticVariation disease BEFREE This study included 126 hypertensive patients with renal artery stenosis (mean age, 63 years; 22.2% fibromuscular dysplasia [FMD]) and investigated the effects of percutaneous transluminal renal angioplasty on office and home blood pressure (BP), and BP variability estimates derived from home BP, both at baseline and up to 12 months after angioplasty. 27872233 2017
CUI: C0016052
Disease: Fibromuscular Dysplasia
Fibromuscular Dysplasia
0.100 GeneticVariation disease BEFREE Using whole-exome sequencing and targeted Sanger sequencing in 19 FMD-affected individuals with no identifiable FLNA mutation, we identified mutations in two genes-MAP3K7, encoding transforming growth factor β (TGF-β)-activated kinase (TAK1), and TAB2, encoding TAK1-associated binding protein 2 (TAB2). 27426733 2016
CUI: C0016052
Disease: Fibromuscular Dysplasia
Fibromuscular Dysplasia
0.100 Biomarker disease BEFREE Mutations in the FLNA gene have been reported in most FMD and OPD2 cases and in all instances of typical OPD1 and MNS. 26404489 2016
CUI: C0016052
Disease: Fibromuscular Dysplasia
Fibromuscular Dysplasia
0.100 GeneticVariation disease BEFREE We hypothesize that the presently reported patients represent further evidence that phenotypes strongly resembling FMD exist that are not accounted for by mutations in FLNA. 25899317 2015
CUI: C0016052
Disease: Fibromuscular Dysplasia
Fibromuscular Dysplasia
0.100 Biomarker disease BEFREE This highlights the importance of the 3A-DCTN3 interaction in FMD virus virulence and provides possible mechanisms of virus attenuation for the development of improved FMD vaccines. 24352458 2014
CUI: C0016052
Disease: Fibromuscular Dysplasia
Fibromuscular Dysplasia
0.100 GeneticVariation disease BEFREE Our data may indicate that in females, genotype-phenotype correlation between certain FLNA mutations and OPD1 and FMD, respectively, is less strict than previously assumed. 16596676 2006
CUI: C0016052
Disease: Fibromuscular Dysplasia
Fibromuscular Dysplasia
0.100 GeneticVariation disease BEFREE OPD1 belongs to a group of X-linked skeletal dysplasias known as oto-palato-digital syndrome spectrum disorders that also include OPD2, Melnick-Needles syndrome (MNS), and frontometaphyseal dysplasia (FMD). 15940695 2005